Share on Facebook  Share on Twitter Share via Mail

Unrelated Donor Bone Marrow Transplantation for Thalassemia: Contrast with Gene Therapy

Mark Walters, MD

Thursday, May 4, 2023, 8:00-9:00 am (San Francisco)  Check your time zone

Image of Mark Walters

In this session Dr. Walters will discuss:

  • Current results of unrelated donor hematopoietic stem cell transplantation (URD HCT) for thalassemia and key determinants that determine outcome
  • URD HCT vs gene therapy for transfusion dependent thalassemias (TDT) with regard to accessibility and other considerations
  • Key curative endpoints in curative therapies for TDT